Cargando…

S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies

Objectives: Chronic primary systemic vasculitidies (CPV) are a collection of rare diseases involving inflammation in blood vessels, often in multiple organs. CPV can affect adults and children and may be life- or organ-threatening. Treatments for adult CPV, although effective, have known severe pote...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Kelly L., Lubieniecka, Joanna M., Armaroli, Giulia, Kessel, Katharina, Gibson, Kristen M., Graham, Jinko, Liu, Dongmeng, Hancock, Robert E. W., Ross, Colin J., Benseler, Susanne M., Luqmani, Raashid A., Cabral, David A., Foell, Dirk, Kessel, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266798/
https://www.ncbi.nlm.nih.gov/pubmed/30533405
http://dx.doi.org/10.3389/fped.2018.00341
_version_ 1783375921628053504
author Brown, Kelly L.
Lubieniecka, Joanna M.
Armaroli, Giulia
Kessel, Katharina
Gibson, Kristen M.
Graham, Jinko
Liu, Dongmeng
Hancock, Robert E. W.
Ross, Colin J.
Benseler, Susanne M.
Luqmani, Raashid A.
Cabral, David A.
Foell, Dirk
Kessel, Christoph
author_facet Brown, Kelly L.
Lubieniecka, Joanna M.
Armaroli, Giulia
Kessel, Katharina
Gibson, Kristen M.
Graham, Jinko
Liu, Dongmeng
Hancock, Robert E. W.
Ross, Colin J.
Benseler, Susanne M.
Luqmani, Raashid A.
Cabral, David A.
Foell, Dirk
Kessel, Christoph
author_sort Brown, Kelly L.
collection PubMed
description Objectives: Chronic primary systemic vasculitidies (CPV) are a collection of rare diseases involving inflammation in blood vessels, often in multiple organs. CPV can affect adults and children and may be life- or organ-threatening. Treatments for adult CPV, although effective, have known severe potential toxicities; safety and efficacy of these drugs in pediatric patients is not fully understood. There is an unmet need for biologic measures to assess the level of disease activity and, in turn, inform treatment choices for stopping, starting, or modifying therapy. This observational study determines if S100 calcium-binding protein A12 (S100A12) and common inflammatory indicators are sensitive markers of disease activity in children and adolescents with CPV that could be used to inform a minimal effective dose of therapy. Methods: Clinical data and sera were collected from 56 participants with CPV at study visits from diagnosis to remission. Serum concentrations of S100A12, C-reactive protein (CRP) and hemoglobin (Hb) as well as whole blood cell counts and erythrocyte sedimentation rate (ESR) were measured. Disease activity was inferred by physician's global assessment (PGA) and the pediatric vasculitis activity score (PVAS). Results: Serum concentrations of standard markers of inflammation (ESR, CRP, Hb, absolute blood neutrophil count), and S100A12 track with clinically assessed disease activity. These measures—particularly neutrophil counts and sera concentrations of S100A12–had the most significant correlation with clinical scores of disease activity in those children with vasculitis that is associated with anti-neutrophil cytoplasmic antibodies (ANCA) against proteinase 3. Conclusions: S100A12 and neutrophil counts should be considered in the assessment of disease activity in children with CPV particularly the most common forms of the disease that involve proteinase 3 ANCA. Key messages: - In children with chronic primary systemic vasculitis (CPV), classical measures of inflammation are not formally considered in scoring of disease activity. - Inflammatory markers—specifically S100A12 and neutrophil count—track preferentially with the most common forms of childhood CPV which affect small to medium sized vessels and involve anti neutrophil cytoplasmic antibodies (ANCA) against proteinase-3.
format Online
Article
Text
id pubmed-6266798
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-62667982018-12-07 S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies Brown, Kelly L. Lubieniecka, Joanna M. Armaroli, Giulia Kessel, Katharina Gibson, Kristen M. Graham, Jinko Liu, Dongmeng Hancock, Robert E. W. Ross, Colin J. Benseler, Susanne M. Luqmani, Raashid A. Cabral, David A. Foell, Dirk Kessel, Christoph Front Pediatr Pediatrics Objectives: Chronic primary systemic vasculitidies (CPV) are a collection of rare diseases involving inflammation in blood vessels, often in multiple organs. CPV can affect adults and children and may be life- or organ-threatening. Treatments for adult CPV, although effective, have known severe potential toxicities; safety and efficacy of these drugs in pediatric patients is not fully understood. There is an unmet need for biologic measures to assess the level of disease activity and, in turn, inform treatment choices for stopping, starting, or modifying therapy. This observational study determines if S100 calcium-binding protein A12 (S100A12) and common inflammatory indicators are sensitive markers of disease activity in children and adolescents with CPV that could be used to inform a minimal effective dose of therapy. Methods: Clinical data and sera were collected from 56 participants with CPV at study visits from diagnosis to remission. Serum concentrations of S100A12, C-reactive protein (CRP) and hemoglobin (Hb) as well as whole blood cell counts and erythrocyte sedimentation rate (ESR) were measured. Disease activity was inferred by physician's global assessment (PGA) and the pediatric vasculitis activity score (PVAS). Results: Serum concentrations of standard markers of inflammation (ESR, CRP, Hb, absolute blood neutrophil count), and S100A12 track with clinically assessed disease activity. These measures—particularly neutrophil counts and sera concentrations of S100A12–had the most significant correlation with clinical scores of disease activity in those children with vasculitis that is associated with anti-neutrophil cytoplasmic antibodies (ANCA) against proteinase 3. Conclusions: S100A12 and neutrophil counts should be considered in the assessment of disease activity in children with CPV particularly the most common forms of the disease that involve proteinase 3 ANCA. Key messages: - In children with chronic primary systemic vasculitis (CPV), classical measures of inflammation are not formally considered in scoring of disease activity. - Inflammatory markers—specifically S100A12 and neutrophil count—track preferentially with the most common forms of childhood CPV which affect small to medium sized vessels and involve anti neutrophil cytoplasmic antibodies (ANCA) against proteinase-3. Frontiers Media S.A. 2018-11-23 /pmc/articles/PMC6266798/ /pubmed/30533405 http://dx.doi.org/10.3389/fped.2018.00341 Text en Copyright © 2018 Brown, Lubieniecka, Armaroli, Kessel, Gibson, Graham, Liu, Hancock, Ross, Benseler, Luqmani, Cabral, Foell, Kessel and the ARChiVe Investigators Network within the PedVas Initiative. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pediatrics
Brown, Kelly L.
Lubieniecka, Joanna M.
Armaroli, Giulia
Kessel, Katharina
Gibson, Kristen M.
Graham, Jinko
Liu, Dongmeng
Hancock, Robert E. W.
Ross, Colin J.
Benseler, Susanne M.
Luqmani, Raashid A.
Cabral, David A.
Foell, Dirk
Kessel, Christoph
S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies
title S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies
title_full S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies
title_fullStr S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies
title_full_unstemmed S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies
title_short S100A12 Serum Levels and PMN Counts Are Elevated in Childhood Systemic Vasculitides Especially Involving Proteinase 3 Specific Anti-neutrophil Cytoplasmic Antibodies
title_sort s100a12 serum levels and pmn counts are elevated in childhood systemic vasculitides especially involving proteinase 3 specific anti-neutrophil cytoplasmic antibodies
topic Pediatrics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266798/
https://www.ncbi.nlm.nih.gov/pubmed/30533405
http://dx.doi.org/10.3389/fped.2018.00341
work_keys_str_mv AT brownkellyl s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT lubienieckajoannam s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT armaroligiulia s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT kesselkatharina s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT gibsonkristenm s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT grahamjinko s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT liudongmeng s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT hancockrobertew s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT rosscolinj s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT benselersusannem s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT luqmaniraashida s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT cabraldavida s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT foelldirk s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies
AT kesselchristoph s100a12serumlevelsandpmncountsareelevatedinchildhoodsystemicvasculitidesespeciallyinvolvingproteinase3specificantineutrophilcytoplasmicantibodies